Homozygosity in Hungtington's disease: New ethical dilemma caused by molecular diagnosis

Clinical Genetics

Volumn 61, Issue 6, 2002, Pages 437-442

  Alonso, Maria Elisa ^a   Yescas, P ^a   Rasmussen, A ^a   Ochoa, A ^a   Macias R ^a   Ruiz, I ^a   Suastegui R ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

Ethics; Genetics counselling; Homozygote; Huntington's disease; Molecular diagnosis

Indexed keywords

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL DOMINANT INHERITANCE; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; DEGENERATIVE DISEASE; DENIAL; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE SEVERITY; EMOTIONALITY; FAMILY; GENE IDENTIFICATION; GENE MUTATION; GENETIC COUNSELING; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUNTINGTON CHOREA; MEDICAL ETHICS; MEDICAL INFORMATION; ONSET AGE; PATIENT ATTITUDE; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROGENY; SIBLING; SYMPTOMATOLOGY; COMPARATIVE STUDY; ETHICS; FAMILY HEALTH; GENETICS; GENETICS AND REPRODUCTION; HETEROZYGOTE; HOMOZYGOTE; MIDDLE AGED; PATHOLOGY; PEDIGREE;

GENETICS AND REPRODUCTION;

AGE OF ONSET; DISEASE PROGRESSION; FAMILY HEALTH; GENETIC COUNSELING; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HUNTINGTON DISEASE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PEDIGREE;

EID: 0036626868     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2002.610607.x     Document Type: Article

References (30)

1. Alonso ME, Nieto D. Aspectos clínicos y genéticos de la enfermedad de Huntington. Estudio de 28 pacientes. Rev Invest Clin 1985: 37: 125-130.
2. Wexler NS. The oracle of DNA. In: Rowland LP, Wood PA, Schan EA, Di Mauro S (Eds) Molecular genetics in diseases of brain, nerve and muscle. Oxford: Oxford University Press, 1989: 429-442.
3. Folstein SE. Huntington's disease. A disorder of families. Baltimore: Johns Hopkins University Press, 1991: 110-120.
4. Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, et al. A polimorphic DNA marker genetically linked to Huntington's disease. Nature 1983: 306: 234-239.
5. Huggins M, Bloch M, Wiggins S, Adam S, Suchowersky O, et al. Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk. Am J Med Genet 1992: 42: 508-515.
6. Brandt J, Quaid KA, Folstein SE, Garber P, Maestri EN et al. Presymptomatic diagnosis of delayed-onset diseases with linked DNA markers: the experience in Huntington's disease. JAMA 1989: 261: 3108-3114.
7. Harper PS, Ball DM, Hayden MR. Presymptomatic testing for Huntington's disease: a world-wide survey. J Med Genet 1983: 30: 1020-1022.
8. Wiggins S, Whyte P, Huggins M, Adam S, Theilmann J, et al. The psychological consequences of predictive testing for Huntington's disease. N Engl J Med 1992: 327: 1401-1405.
9. Benjamin CM, Adam S, Wiggins S, Theilmann JL, Copley TT, et al. Proceed with care: direct predictive testing for Huntington's disease. Am J Hum Genet 1994: 55: 606-617.
10. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993: 72: 971-983.
11. ACMG/ASHG, Statement. Laboratory guidelines for Huntington disease genetic testing. Am J Hum Genet 1998: 62: 1243.
12. Goldberg YP, Andrew SE, Theilmann J, Kremer B, Squitieri F, Telenius H, et al. Familial predisposition to recurrent mutations causing Huntington's disease: genetic risk to sibs of sporadic cases. J Med Genet 1993: 30: 987-990.
13. Leavitt BR, Wellington CL, Hayden MR. Recent insights into the molecular pathogenesis of Huntington disease. Sem Neurol 1999: 19: 385-395.
14. Rubinsztein DC, Leggo, J, Coles R, Almqvist E, Biancalana V, et al. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet 1996: 59: 16-22.
15. McNeil SM, Novelletto A, Srinidhi J, Barnes G, Kornbluth I, et al. Reduced penetrance of the Huntington's disease mutation. Hum Mol Genet 1997: 6: 775-779.
16. Falush D, Almqvist EW, Brinkmann RR, Iwasa Y, Hayden MR. Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases. Am J Hum Genet 2000: 68: 373-385.
17. De Rooij KE, De Koning Gans PAM, Skraastad MI, Belfroid RDM, Vegter-Van Der Ulis M, et al. Dynamic mutation in Dutch Huntington's disease patients: increased paternal repeat instability extending to with the normal size range. J Med Genet 1993: 30: 996-1002.
18. Dürr A, Hahn-Barma V, Brice A. Homozygosity in Huntington's disease. J Med Genet 1999: 36: 172-173.
19. Wexler NS, Young AB, Tanzi RE, Travers H, Starosta-Rubinstein S, et al. Homozygotes for Huntington's disease. Nature 1987: 326: 194-197.
20. Huntington Study Group. Unified Huntington's disease rating scale: reliability consistency. Mov Disorders 1996: 11: 136-142.
21. Marder K, Zhao H, Myers RH, Cudkowicz M, Kayson E, et al. Rate of functional decline in Huntington's disease. Huntington Study Group. Neurol 2000: 54: 452-458.
22. Alonso ME, Yescas P, Cisneros B, Mtz C, Silva G, Ochoa A, et al. Analysis of the (CAG)n repeat causing Huntington's disease in a Mexican population. Clin Genet 1997: 51: 225-230.
23. Myers RH, Leavitt J, Farrer LA, Jagodeesh J, McFarlane H, Mastromauro CA, et al. Homozygote for Huntington's disease. Am J Hum Genet 1989: 45: 615-618.
24. Sanchez A, Castellvi-Bel S, Mila M, Genis D, Calopa M, Jimenez D, et al. Huntington's disease: confirmation of diagnosis and presymptomatic testing in Spanish families by genetic analysis. J Neurol Neurosurg Psychiatry 1996: 61: 625-627.
25. Kremer B, Golberg P, Andrew SE, Theilmann J, Telenius H, et al. A worlwide study of the Huntington's disease mutation the sensitivity and specificity of measuring CAG repeats. New Engl J Med 1994: 336: 1401-1406.
26. Matsumura R, Futamura N, Fujimoto Y, Yamagimoto Y, Hoxikawa H, Suzymura A, et al. Spinocerebellar ataxia type 6. Molecular and clinical features of 35 Japanese patients including one homozygous for the CAG repeat expansion. Neurology 1997: 49: 1238-1243.
27. Sobue G, Doyu M, Shimada N, Mitsuma T, Maruyama H, et al. Homozygosity for Machado-Joseph disease gene enhances phenotypic severity. J Neurol Neurosurg Psychiatry 1996: 60: 354-357.
28. International Huntington Association and the World Federation of Neurology Research Group on Huntington's Chorea. Guidelines for the molecular genetics predictive testing in Huntington's disease. Neurology 1994: 44: 1533-1535.
29. Almqvist EW, Bloch M, Brinkman R, Craufurd D, Hayden MR, on behalf of an international collaborative group. A world-wide assessment of the frequency of suicide, suicide attempts or psychiatric hospitalization after predictive testing for Huntington disease. Am J Hum Genet 1999: 64: 1293-1304.
30. Lisker R, Carnevale A, Armendares S. Mexican geneticists views of ethical issues in genetics testing and screening. Are eugenic principles involved? Clin Genet 1999: 56: 323-327.